Clinical Trials

Title   RIN-PH-202 An Open -Label Extension Study of Inhaled Treprostinil in Subjects with pulmonary Hypertension due to Parenchymal Lung Disease
IRB Number   18-036
Treatment   Pulmonary Arterial Hypertension
Status   Active
Start Date   02/19/2018
Principal Name   Karen Fagan
Contact Name   Erica Sutherland

Email Newsletters

Connect With Us